Afuco™ Anti-Human CLEC12A ADCC Recombinant Antibody, ADCC Enhanced

CAT#: AFC-161CL

Anti-CLEC12A ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is an antibodiy that specifically bind to human CLL-1, in particular to the extracellular domain of a CLL-1 expressing cell. The CLL-1 antibodies can inhibit cancer cell growth (proliferation and/or engraftment) and thus can be considered chemotherapeutic agents alone.

Gene Expression
Figure 1 Colon Figure 2 Kidney Figure 3 High expression in bone marrow Figure 4 RNA cell line category: Group enriched (HL-60, U-937)

Specifications

  • Host Species
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Related Disease
  • Hematologic malignancies

Product Property

  • Purity
  • >97%, by SDS-PAGE under reducing conditions
  • Storage
  • Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.

Target

  • Alternative Names
  • CLEC12A; C-type lectin domain family 12, member A; CLL1; MICL; CLL-1; DCAL-2; C-type lectin domain family 12 member A; C-type lectin protein CLL-1; C-type lectin-like molecule-1; dendritic cell-associated lectin 2; myeloid inhibitory C-type lectin-like receptor
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-161CL. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "CLEC12A"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
VS-0225-XY84 CytoStream™ Mouse Anti-CLEC12A Recombinant Antibody (clone 50C1) FC Mouse IgG2a, kappa
CAT Product Name Application Type
VS-0325-FY10 Human Anti-CLEC12A scFv-Fc Chimera (VS-0325-FY10) ELISA, FC Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0325-XY467 Anti-CLEC12A Immunohistochemistry Kit IHC
CAT Product Name Application Type
VS-0425-YC129 Recombinant Anti-CLEC12A Vesicular Antibody, EV Displayed (VS-0425-YC129) ELISA, FC, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare